← All stocks

Moleculin Biotech, Inc.

MBRX Net buying
CIK 0001659617 #5204 in the set updated 18 Sep 2026
Bought (120 mo)
$721.49K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$340.60K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$340.60K
2 of 2 sales
Net
+$380.89K
+$380.89K against sales at will

By person

6 insiders · 18 transactions
0.3×

Walter V. Klemp holds only 0.3 times base salary in stock. $208.81K of shares against $565.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Walter V. Klemp last reported holding, valued at $0.37, the price Common Stock was last bought or sold at on the open market here, on 23 Jun 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
KLEMP WALTER V
CEO and President
$581.09K (8)
$170.30K (1)
+$410.79K
564,340
$208.81K
Priebe Waldemar
10% owner
$170.30K (1)
−$170.30K
2,781,573
$1.03M
−3.5%
Foster Jonathan P.
Chief Financial Officer
$128.65K (4)
+$128.65K
305,673
$113.10K
George Robert E.
Director
$10.94K (2)
+$10.94K
14,660
$5.42K
Northcut Jacqueline
Director
$820.00 (1)
+$820.00
1,000
$370.00
PICKER DONALD H
Chief Science Officer
(1)
$0.00
174,086
$64.41K

No percentages here. This company's share count has moved by a factor of 17.0 over the window, from 3,001,895 to 50,910,476 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 121
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 3
Shares from compensation/vesting 573,920
Sales filed before the plan box existed 2
History held since 27 Sep 2016